Medicare+Choice:
Oversight Lapses in HCFA's Review of Humana's 1998 Florida Contract
GAO-01-176R: Published: Nov 27, 2000. Publicly Released: Nov 27, 2000.
Additional Materials:
- Full Report:
Contact:
(202) 512-8942
contact@gao.gov
Office of Public Affairs
(202) 512-4800
youngc1@gao.gov
Humana, Inc., a large Medicare Choice Plan, provided a prescription drug benefit with a coverage limit that was below the amount listed in its 1998 Florida Medicare Choice contract. Ernst and Young, the contractor hired by the Health Care Financing Administration (HCFA) to review Humana's contract submission, did not detect the discrepancies because it failed to follow HCFA's review procedures. HCFA has revised its processes and procedures for monitoring the accuracy of the information in Medicare Choice plans' contracts. The Humana case shows that the agency did not follow procedures that could have revealed the contract discrepancies that caused some beneficiaries to receive less coverage for brand name prescription drugs than the amount specified in their plan's basic package. Unless HCFA adheres to its revised monitoring procedures, beneficiaries will have few guarantees that they will receive the prescription drug benefits for which the government contracted and paid.
Jan 21, 2021
Rural Hospital Closures:
Affected Residents Had Reduced Access to Health Care ServicesGAO-21-93: Published: Dec 22, 2020. Publicly Released: Jan 21, 2021.-
Health Care Funding:
Federal Obligations to and Funds Received by Certain Organizations Involved in Health-Related Services, 2016 through 2018GAO-21-188R: Published: Dec 21, 2020. Publicly Released: Jan 21, 2021.
Jan 14, 2021
-
Medicaid:
Data Completeness and Accuracy Have Improved, Though Not All Standards Have Been MetGAO-21-196: Published: Jan 14, 2021. Publicly Released: Jan 14, 2021.
Jan 4, 2021
-
Medicare Severe Wound Care:
Spending Declines May Reflect Site of Care Changes; Limited Information Is Available on QualityGAO-21-92: Published: Jan 4, 2021. Publicly Released: Jan 4, 2021.
Dec 22, 2020
-
Defense Health Care:
Efforts to Ensure Beneficiaries Access Specialty Care and Receive Timely and Effective CareGAO-21-143: Published: Dec 22, 2020. Publicly Released: Dec 22, 2020.
Dec 16, 2020
-
Medicaid Long-Term Services and Supports:
Access and Quality Problems in Managed Care Demand Improved OversightGAO-21-49: Published: Nov 16, 2020. Publicly Released: Dec 16, 2020.
Dec 14, 2020
-
Drug Pricing Program:
HHS Uses Multiple Mechanisms to Help Ensure Compliance with 340B RequirementsGAO-21-107: Published: Dec 14, 2020. Publicly Released: Dec 14, 2020. -
Substance Use Disorder:
Reliable Data Needed for Substance Abuse Prevention and Treatment Block Grant ProgramGAO-21-58: Published: Dec 14, 2020. Publicly Released: Dec 14, 2020.
Dec 10, 2020
-
Indian Health Service:
Actions Needed to Improve Oversight of Provider Misconduct and Substandard PerformanceGAO-21-97: Published: Dec 10, 2020. Publicly Released: Dec 10, 2020. -
Clinical Labs:
Studies Suggest Biopsy Specimen Misidentification and Contamination Errors Are InfrequentGAO-21-59: Published: Nov 10, 2020. Publicly Released: Dec 10, 2020.
Looking for more? Browse all our products here
Explore our Key Issues on Health Care
- Air Quality
- Border Security and Immigration
- Children's Health and Safety
- Drug Misuse
- Elder Abuse
- Health Care Quality
- Health Information Technology
- Improper Payments
- Improving Federal Programs that Serve Tribes and Their Members - High Risk Issue
- Managing Risks and Improving VA Health Care
- Medicaid - High Risk Issue
- Medical Product Oversight - High Risk Issue
- Medicare - High Risk Issue
- Prescription Drug Spending
- Supports and Services for Transitioning Veterans
- Toxic Chemicals - High Risk Issue
- Tribal and Native American Issues
- VA and DOD Health Care Management
- VA and DOD Patient Care
- Women and Gender in Public Policy
Explore our other Key Issues here
